Prophase Labs Inc (NASDAQ:PRPH)
| 11.34 Delayed Data As of Aug 05 |  +0.58 / +5.37%Today’s Change | 4.76 Today|||52-Week Range 15.25 | +58.16% Year-to-Date |
Latest PRPH News | Press Releases
| ProPhase Labs, Inc. (PRPH) Dips More Than Broader Markets: What You Should Know Aug 02 / Zacks.com - Paid Partner Content | Strength Seen in ProPhase Labs, Inc. (PRPH): Can Its 8% Jump Turn into More Strength? Jul 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.81 |
| Today’s open | 10.87 |
| Day’s range | 10.83 - 11.65 |
| Volume | 148,230 |
| Average volume (3 months) | 127,849 |
| Market cap | $163.5M |
Data as of 4:03pm ET, 08/05/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +127.50% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +444.59% |
| P/E ratio | 11.1 |
| Price/Sales | 1.67 |
| Price/Book | 2.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HROWHarrow Health Inc | -0.05 | -0.75% |
| PBYIPuma Biotechnology I... | +0.57 | +17.43% |
| ASRTAssertio Holdings In... | -0.01 | -0.25% |
| FENCFennec Pharmaceutica... | +0.25 | +3.63% |
Data as of 4:03pm ET, 08/05/2022
Financials
| Next reporting date | August 12, 2022 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $79.0M |
| Annual profit (last year) | $6.3M |
| Net profit margin | 7.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Garden City, New York |
Forecasts
